Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and occurs predominantly in patients with underlying chronic liver disease and cirrhosis. It is considered as the second leading cause of cancer-related death worldwide with over 500,000 people affected. Incidence of the HCC is highest in Asia and Africa, where the endemic high prevalence of hepatitis B and C strongly predisposes to development of the chronic liver disease and subsequent development of HCC. In most cases, the cause of liver cancer is long-term damage and scarring of the liver cirrhosis that may be caused by viral infections (Virus B or C) or non-viral causes such as non-Alcoholic Fatty Liver Disease (NAFLD), autoimmune diseases, inflammation of the liver (chronic), obesity, diabetes, alcohol consumption, smoking, iron overload in the body (hemochromatosis) and the exposure to aflatoxin. The recent studies concluded that vaccination and the antiviral treatment are the most important ways for the HCC prevention.
Introduction
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy that is considered as the second leading cause of cancer-related death worldwide 1 . The studies which were carried out with over half a million new cases diagnosed annually worldwide, it was reported that HCC is the fifth most common cancer in men and seventh among women 2 . The HCC is particularly lethal with a 5-year survival of less than 5% of the patients who are not transplant candidates 3 . A total of 30 new liver cancers and 640 intrahepatic bile duct cancers were estimated during 2013 4 . In 2010, Ferlay et al. 5 documented that HCC occurred more often in males than females (2.4:1) with a higher incidence in Eastern and Southern Asia, Middle and Western Africa, Melanesia and Micronesia/Polynesia.
Moreover, it was found that the age-adjusted incidence of liver cancer has risen from 1.6 per 100,000 individuals to 4.6 per 100,000 individuals among American Indians and Alaskan Natives followed by blacks, whites and hispanics 6 . In the United
States, incidence of the HCC increases with a more than two fold from 1976 to 2002 [7] [8] [9] . A significant proportion of this increase is accounted for by the growing prevalence of hepatitis C virus (HCV) infection 10 . .
Non-viral causes of hepatocellular carcinoma

Non-Alcoholic Fatty Liver Disease (NAFLD)
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder in western countries, with ~20% of individuals 
Obesity
Prevalence of obesity has increased to epidemic proportions over the last three decades. Excess body mass is classified as overweight if the BMI is > 25 kg/m2 and <30 kg/m2, or obese if the BMI is ≥ 30 kg/m2. In addition to the increase in an array of disease processes observed with being overweight or obese, both classifications of excess body mass are associated with a higher risk of developing all cancers including liver cancer 33, 34 .
In addition to an increased risk of developing HCC, overweight or obese patients appear to be at increased risk for HCC-related mortality. In a population-based study of cancer mortality and BMI, men with a BMI of 30-34.9 were found to have a two fold increase in the risk of death from HCC, with a 4.5-fold increase noted in men with BMI > 35 33 .
Diabetes
Diabetes has been found to increase the risk of developingchronic liver disease and HCC .
Diet
Some studies have examined whether alterations in diethave an effect on the risk of HCC. A trial from Italy hasexamined a broad range of dietary habits among 185patients with HCC and 412 patients without cancer 41, 42 . Those with HCC were more likely to protective effect against HCC. The enthusiasmfor these findings however should be tempered bythe fact that the majority of these studies were retrospectivein nature 48 .
Coffee
Coffee consumption has also been studied and appears to have a potentially favorable effect on the prevention of liver diseases, including HCC 49, 50 . There are several hypotheses that could explain why consuming coffee attenuates the risk of developing HCC. One hypothesis argues that coffee intake lowers serum levels of γ-glutamyltransferase (GGT), which is associated with a lower incidence of HCC [50] [51] [52] [53] ]. Coffee consumption has also been linked to a lower incidence of cirrhosis which is a major risk factor for the development of HCC 
Alcohol
Alcohol consumption remains an important risk factorfor the development of HCC Studies in Europe reported an increase in the relative risk of developing liver disease above 7-13 drinks per week in women and 14-27 drinks per week in men 59, 61 . In the United States, studies showed that the risk of liver cancer is increased two to four fold among persons drinking more than 60 g/d of ethanol 62 .
A meta-analysis of 19 prospective studies showed that consumption of three or more drinks per day resulted in a 16%
increase risk of liver cancer and consumption of six or more drinks per day resulted in a 22% increase risk 63 .
Smoking
Other risk factors may include smoking. Cigarette smoking is associated with a significant increase in the development of 
Aflatoxin
Aflatoxin B1 (AFB1) is the major metabolite of the molds Aspergillus fumigatus and Aspergillus parasiticus. These moldsgrow on a variety of food products that are stored inwarm and damp conditions or are cultivated in countrieswith hot and humid climates 65, 66 . AFB1 induces a singlenucleotide substitution in codon 249 in the p53 tumor suppressor gene, which results in the change of the aminoacid arginine to serine 67, 68 . This mutation is present in upto 50% of patients with HCC who are indigenous to geographicregions with high exposure to AFB1 [69] [70] .On theother hand, this mutation is absent in patients with HCC from regions with low exposure to AFB1 71, 72 . Moreover,it has been recently demonstrated that AFB1-albumin adductsin patients with HCC correlate significantly with thepresence of plasma DNA hypermethylation and mutationsin the p16 and p53 tumor suppressor genes 73 .
Host genetic factors
Host geneticmakeup may be an important factor that influences progression to HCC. Two meta-analysisindentified variants of tumor necrosis factor (TNF) associated with higher risk of HCC.They showed that TNFα-308 AA and AG variants (vs. GG)
were associated with asignificantly increased risk of HCC 74, 75 . 
HBV vaccination
Development of HBV vaccine has been a major success in 
Antiviral treatment
Antiviral treatment is also considered as one of the most important ways for the HCC prevention. A met analysis of nonrandomized trials and observational studies demonstrated reduced risk of HCC after anti-viral treatment for HBV infection.
A multicenter randomized controlled study on patients with chronic HBV and advanced hepatic fibrosis showed that 3.9%
developed HCC on lamivudine therapy as compared to 7.4% in placebo arm when treated up to 5 years 78 .
In addition, the randomized and non-randomized studies have
shown that achieving sustained viral response in chronic HCV patients, both with and without cirrhosis, leads to a substantial reduction in risk of HCC 79, 80 . .
Conclusion
The study concluded that cause of the liver cancer is long-term damage and scarring of the liver cirrhosis that may be caused by viral infections (Virus B or C) or non-viral causes such as NAFLD, autoimmune diseases, inflammation of the liver (chronic), obesity, diabetes, alcohol consumption, smoking, iron overload in the body and the exposure to aflatoxin.
Furthermore, vaccination and the antiviral treatment are the most important ways for prevention of the HCC.
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